For a better user experience please update your browser or use Chrome or Firefox browser.
Utilitajiet
Publication detail
HomeOpinion on citral (CAS No. 5392-40-5, EC No. 226-394-6) sensitisation endpoint
Metadejta tal-pubblikazzjoni
The SCCS has noted that the QRA2 methodology has indicated that Citral can be considered safe in relation to the induction of sensitisation at the concentrations proposed for use in cosmetic products. However, the SCCS has identified some aspects of the QRA2 methodology that still need clarification and therefore, some refinement is needed before a firm conclusion on the safety of Citral could be drawn.
- Ippubblikat:
- Awtur(i) korporattiv(i): Directorate-General for Health and Food Safety (Il-Kummissjoni Ewropea)
- Temi Industrija farmaċewtika u kosmetika , Riċerka teknika u xjentifika
- Suġġett: kompost kimiku , prodott kożmetiku , regolament (UE) , saħħa pubblika , sikurezza tal-prodotti , sustanza tossika , ġestjoni tar-riskju
|
PDF
|
|||
| ISSN 1831-4767 | ISBN 978-92-68-28865-8 | DOI 10.2875/8141845 | Numru tal-Katalogu EW-01-25-081-EN-N |
- Released on EU publications website:
Viżwalizzatur tad-dokument
Note:
Il-pubblikazzjoni ma tistax tintwera fil-viżwalizzatur tad-dokument. Verżjoni miftuħa fuq l-internet
Tista’ taċċessaha minn: Iddawnlowdjar u lingwi